The existence of the EGFR-C797S or other 3rd generation-resistant mutations [17], c-MET amplification or the transformation of the NSCLC into a small cell lung cancer (SCLC) [18] are already recognized processes, among others, as the cause of this acquired resistance. This evidence concerns the gene MET and small cell lung carcinoma.